Effects of organophosphates on the visual system of rats.
The possibility that exposure to organophosphate insecticides can lead to ocular damage is suggested by Japanese studies from the 1960s and 1970s indicating that exposed humans developed chronic ocular degeneration, in addition to showing more commonly accepted effects of cholinesterase-inhibiting compounds. Other papers reported ocular lesions in laboratory animals treated with organophosphates. More recently, retinal degeneration following chronic organophosphate treatment has been reported to the Environmental Protection Agency by pesticide manufacturers in studies conducted in compliance with good laboratory practice regulations. Several factors, however, have prompted scepticism regarding organophosphate-induced ocular toxicity, including the widespread use of organophosphate compounds for both agricultural and ophthalmological practices without numerous additional reports of comparable ocular toxicity. We are developing a research program to address these issues involving electrophysiological, biochemical and histological investigations of rats treated with organophosphate insecticides. The research program is young, but early results are available. Notably, retinas from rats treated with a single subcutaneous injection of 100 mg kg-1 fenthion showed decreases in carbachol-stimulated release of inositol phosphate, an indicator of cholinergically-mediated intracellular second messenger systems. These effects persisted at least 56 days after fenthion administration. This could indicate several different toxicological actions, which are currently under investigation. It is concluded that the possible association between exposure to organophosphates and ocular toxicity cannot be dismissed, and that several important research issues need to be resolved.
Boyes
W K
WK
Neurotoxicology Division, United States Environmental Protection Agency, Research Triangle Park, NC.
Tandon
P
P
Barone
S
S
Padilla
S
S
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000009:adverse effects; D002802:Cholinesterases / Q000378:metabolism; D004596:Electroretinography; D005074:Evoked Potentials, Visual / Q000187:drug effects*; D005123:Eye / Q000187:drug effects* / Q000473:pathology; D005284:Fenthion / Q000633:toxicity; D006801:Humans; D007306:Insecticides / Q000009:adverse effects; D009943:Organophosphorus Compounds / Q000009:adverse effects / Q000633:toxicity*; D051381:Rats; D012106:Research; D012160:Retina / Q000187:drug effects / Q000201:enzymology
D002800:Cholinesterase Inhibitors; D007306:Insecticides; D009943:Organophosphorus Compounds; D005284:Fenthion; D002802:Cholinesterases